Zobrazeno 1 - 10
of 6 412
pro vyhledávání: '"Chimeras"'
Autor:
Jeon, Byeong Wook1,2 (AUTHOR), Kang, Na Young1,2 (AUTHOR), Park, Won‐Yong3 (AUTHOR), Oh, Eunkyoo3 (AUTHOR), Kim, Jungmook1,2,4 (AUTHOR) jungmkim@jnu.ac.kr
Publikováno v:
Physiologia Plantarum. Jan/Feb2024, Vol. 176 Issue 1, p1-9. 9p.
Autor:
Jinglei Hu, Mingxia Liu, Dongxia Wang, Yunlong Liang, Yuan Zong, Yun Li, Dong Cao, Baolong Liu
Publikováno v:
Frontiers in Plant Science; 2024, p01-10, 10p
Autor:
Jun-dan Jia, Yu-feng Qiao
Publikováno v:
Linchuang shenzangbing zazhi, Vol 24, Iss 10, Pp 860-864 (2024)
Acute kidney injury （AKI） is a diverse group of renal diseases characterized by a dramatic decline in renal function. Not only AKI has a high mortality rate， but also poor renal adaptation or incomplete repair after acute phase may also lead to
Externí odkaz:
https://doaj.org/article/3fa9c1ca850040109f16cc68bd551e38
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-24 (2024)
Abstract Targeted therapies, such as small molecule kinase inhibitors, have made significant progress in the treatment of hematologic malignancies by directly modulating protein activity. However, issues such as drug toxicity, drug resistance due to
Externí odkaz:
https://doaj.org/article/44aa040c0e97457dbd58f150108b00d7
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 5739-5761 (2024)
Yue Song,1,* Qing-Qing Dong,2,* Yi-Ke Ni,3 Xiao-Ling Xu,3 Chao-Xiang Chen,3 Wei Chen2 1Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, 310003, People’s Republic of China; 2IC
Externí odkaz:
https://doaj.org/article/67bbc2909b7044e09f51319340a86d5a
Autor:
Michno, Jean-Michel1,2 (AUTHOR), Virdi, Kamaldeep2 (AUTHOR), Stec, Adrian O.2 (AUTHOR), Liu, Junqi2 (AUTHOR), Wang, Xiaobo2,3 (AUTHOR), Xiong, Yer2 (AUTHOR), Stupar, Robert M.1,2 (AUTHOR) stup0004@umn.edu
Publikováno v:
BMC Biotechnology. 2/24/2020, Vol. 20 Issue 1, p1-13. 13p.
Autor:
Si-Han Zhang, Na Zeng, Jin-Zhou Xu, Chen-Qian Liu, Meng-Yao Xu, Jian-Xuan Sun, Ye An, Xing-Yu Zhong, Lin-Tao Miao, Shao-Gang Wang, Qi-Dong Xia
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 180, Iss , Pp 117584- (2024)
Proteolysis Targeting Chimera (PROTAC) is an emerging and evolving technology based on targeted protein degradation (TPD). Small molecule PROTACs have shown great efficacy in degrading disease-specific proteins in preclinical and clinical studies, bu
Externí odkaz:
https://doaj.org/article/2a2bf195cb1843d0a540156ade3c2d46
